Synthetic cannabinoid analogs, pharmaceutical compositions and methods of treating anxiety and other disorders
MX2026009553APending Publication Date: 2026-10-02MIRALOGX LLC +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MX2026009553
- Authority / Receiving Office
- MX · MX
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-02-25
- Filing Date
- 2026-07-30
- Publication Date
- 2026-10-02
Abstract
Cannabinoid analogs may exhibit anti-inflammatory properties such as by inhibition of cannabinoid type 2 (CB2) receptors. Pharmaceutical compositions comprising the cannabinoid analogs may be used to treat various diseases and conditions in mammals, including pain, anxiety, a sleep disorder, addiction, epilepsy, depression, post-traumatic stress disorder or Alzheimer's disease. In some examples, the pharmaceutical compositions may be administered for treating a cognitive disorder or for improving cognition.
Need to check novelty before this filing date? Find Prior Art